Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Novartis
US Department of Justice
Covington
McKinsey
Citi
UBS
Dow
Federal Trade Commission

Generated: October 17, 2017

DrugPatentWatch Database Preview

JENLOGA Drug Profile

« Back to Dashboard

Which patents cover Jenloga, and when can generic versions of Jenloga launch?

Jenloga is a drug marketed by Concordia Pharms Inc and is included in one NDA.

The generic ingredient in JENLOGA is clonidine hydrochloride. There are twenty-two drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the clonidine hydrochloride profile page.

Summary for Tradename: JENLOGA

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list70
Patent Applications: see list1,350
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:JENLOGA at DailyMed

Pharmacology for Tradename: JENLOGA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-001Sep 30, 2009DISCNYesNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-002May 25, 2010DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: JENLOGA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-001Sep 30, 2009► Subscribe► Subscribe
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-002May 25, 2010► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for JENLOGA

Drugname Dosage Strength RLD Submissiondate
clonidine hydrochlorideExtended-release Tablets0.1 mg and 0.2 mgJenloga3/4/2011
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Merck
Cantor Fitzgerald
Moodys
Covington
Fuji
Chubb
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot